Tech Center 1600 • Art Units: 1623 1657 1673 1693
This examiner grants 73% of resolved cases
Traviss C. McIntosh III is an examiner in Tech Center 1600 and Art Unit 1623. The examiner has 1334 resolved cases and an allowance rate of 73.2 percent. The median days to allowance is 885, which establishes a benchmark for the duration of the prosecution process. These statistics are derived from a large volume of work in this technical area.
The interview lift of 14.0 percent is an important metric for applicants. This figure shows the increase in the probability of allowance after an interview compared to the baseline allowance rate of 73.2 percent. A 14.0 percent lift suggests that verbal engagement is a productive strategy for resolving issues. The 885-day median to allowance provides a timeline for expectations when prosecuting cases before this examiner. With 1334 resolved cases, the data reflects a stable pattern of behavior. The 73.2 percent allowance rate indicates that a majority of applications reach a grant, and the 14.0 percent lift can further improve those odds.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18439034 | STABILIZATION OF OLIGONUCLEOTIDE AND OLIGONUCLEOTIDE-PROTEIN COMPLEX USING ALKYLATED PHOSPHATE | Non-Final OA | UNIVERSITY OF MASSACHUSETTS |
| 18675302 | ENZYMATIC SYNTHESIS OF 4'-ETHYNYL NUCLEOSIDE ANALOGS | Non-Final OA | Merck Sharp & Dohme LLC |
| 18704503 | FINE CELLULOSE FIBER POWDER AND METHOD FOR PRODUCING FINE CELLULOSE FIBER POWDER | Non-Final OA | Yokogawa Electric Corporation |
| 18835699 | METHOD FOR PRODUCING OLIGONUCLEOTIDES | Non-Final OA | Nitto Denko Corporation |
| 18258731 | PENETRATING CRYOPROTECTION AGENTS AND METHODS OF MAKING AND USING SAME | Final Rejection | The Research Foundation for The State University of New York |
| 18720093 | A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OTIC INFECTIONS | Non-Final OA | Intervet Inc. |
| 18022855 | PROCESS FOR THE DIRECT CONVERSION OF CELLULOSE TO GLYCOLS USING NON-NOBLE METAL LOADED ZEOLITE CATALYSTS | Non-Final OA | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy